1. Tollman P, Guy P, Altshuler J, Flanagan A, Steiner M.A revolution in R&D: how genomics and genetics are transforming the biopharmaceutical industryBoston Consulting Group, November 2001. Available at:www.bcg.com/publications/files/eng_genomicsgenetics_rep_11_01.pdf.Accessed April 24, 2002.
2. National Institutes of Health and Food and Drug Administration.Biomarkers and surrogate endpoints: advancing clinical research and applications—a multidisciplinary, international conference sponsored by NIH and FDA.Available at:www4.od.nih.gov/biomarkers/.Accessed February 13 2003.
3. 1938 Federal Food, Drug, and Cosmetic Act.Pub L No. 75-717, 52 Stat 1040, 21 USC §301–§3941938.
4. The Architecture of Government Regulation of Medical Products
5. Annas GJ.Faith (healing), hope and charity at FDA: the politics of AIDS drug trials.Villanova Law Rev1989; 34:771-797.